Skip to content

Insider · CIK 0001802687

Andrew John Hugh MacIntyre Sims

cfoofficer

Files at CNSY (PLUS THERAPEUTICS, INC.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Common Stock
+1,533$0.00$011,47411 d ago
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Common Stock
+1,165$0.00$012,63911 d ago
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Common Stock
+287$0.00$012,92611 d ago
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Restricted Stock Unitsderivative
-1,533$0.00$025,53711 d ago
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Restricted Stock Unitsderivative
-1,165$0.00$024,37211 d ago
Oct 1, 2026CNSY
PLUS THERAPEUTICS, INC.
MOption exercise
Restricted Stock Unitsderivative
-287$0.00$024,08511 d ago
Aug 13, 2025CNSY
PLUS THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+1,379,636$0.00$01,379,636Aug 15, 2025
Aug 13, 2025CNSY
PLUS THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivative
+459,878$0.00$0459,878Aug 15, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew John Hugh MacIntyre Sims: insider trades and track record | InsiderTell